Connect with us

Health

Johnson & Johnson vaccine: Why it’s worth the minuscule risk – Inverse

The benefits for the one-dose Covid-19 vaccine outweigh the risks.

Published

on

Article feature image

The CDC and the FDA lifted the pause
on the Johnson & Johnson Covid-19 vaccine on April 23, 2021, but the labels and fact sheets given to patients will carry a warning about the exceedingly low risk of developing blood clots.
Also, close monitoring of the J&J vaccine along with the Moderna and Pfizer vaccines that were given emergency use authorization will continue.
Dr. William Petri, an infectious disease physician and immunologist at the University of Virginia School of Medicine, explains…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending